Market Purchase of Shares for EBT

Summary by AI ^BETAClose X

Luceco plc announced that its Employee Benefit Trust, managed by Apex Financial Services, purchased 2,000,000 ordinary shares at a price of £2.09925 per share on April 24, 2026. Following this transaction, the Trust will hold a total of 13,609,743 shares, representing 8.46% of the company's issued ordinary share capital, to satisfy future awards to potential beneficiaries, including executive directors and persons discharging managerial responsibilities.

Disclaimer*

Luceco PLC

27 April 2026

Luceco plc

(the "Company")

Luceco plc announces market purchase of shares for its Employee Benefit Trust

Luceco Plc (Luceco or the Company) was notified by Apex Financial Services (Trust Company) Limited (Apex), acting as trustee of the Luceco plc Employee Benefit Trust (the Trust), that Apex purchased in the market a total of 2,000,000 Luceco ordinary shares with a nominal value of £0.0005 each (Shares) as set out in the table below.

The Trust holds the Shares for the purpose of satisfying awards to be awarded to beneficiaries of the Trust. The executive directors and persons discharging managerial responsibility on behalf of the Company are potential beneficiaries under the Trust and are therefore treated as having an interest in such Shares. Upon settlement of the above transaction, the Trust will hold a total of 13,609,743 Shares, representing 8.46% of Luceco's issued ordinary share capital.

Number of shares purchased	Transaction price (per share)	Date of transaction
2,000,000	2.09925	24 April 2026

27 April 2026

LEI: 213800BBFZK4W4P98U76

- ENDS-

For further information please contact:

Luceco plc

Will Hoy, Chief Financial Officer

via the Company Secretary, MUFG Corporate Markets

0333 300 1932 (via MUFG Corporate Markets)

MUFG Corporate Markets

Karen Waldron

0333 300 1932

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END